CTTI would like to welcome our newest members, Alexion Pharmaceuticals, Inc. and Pharmaceutical Research and Manufacturers of America (PhRMA).

Alexion Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and delivering therapies for patients with rare diseases. Alexion’s Vice President of Research and Development Quality, Coleen Glessner, will represent this organization on CTTI’s Steering Committee.

PhRMA is a non-profit membership association that represents the country’s leading pharmaceutical research and biotechnology companies. PhRMA’s Senior Director of Science and Regulatory Advocacy, Jocelyn Ulrich, will represent this organization on CTTI’s Steering Committee.

We are pleased to have these two new voices involved with CTTI’s work. CTTI actively engages all stakeholders equally to collaboratively improve the quality and efficiency of the clinical trials enterprise. For more information about the diverse representation of CTTI’s membership, click here.